Effect of Different Classes of Antihypertensive Drugs on Endothelial Function and Inflammation
Year: 2019
Type: review
Abstract: Hypertension is characterized by structural and functional changes in blood vessels that travel with increased arterial stiffness, vascular inflammation, and endothelial dysfunction. Some antihypertensive drugs have been shown to improve endothelial function and reduce levels of inflammatory markers regardless of the effect of blood pressure lowering. Third-generation β-blockers, such as nebivolol and carvedilol, because they have additional properties, have been shown to improve endothelial function in patients with hypertension. Calcium channel antagonists, because they have antioxidant effects, may improve endothelial function and vascular inflammation.The Angiotensin Receptor Blocker (ARBs) are able to improve endothelial dysfunction and vascular inflammation in patients with hypertension and other cardiovascular diseases. Angiotensin converting enzyme (ACE) inhibitors have shown beneficial effects on endothelial function in patients with hypertension and other cardiovascular diseases, however there are few studies evaluating the effect of treatment with this class on the reduction of C-reactive protein (CRP) levels. Further studies are needed to assess whether treatment of endothelial dysfunction and vascular inflammation may improve the prognosis of patients with essential hypertension.
DOI: 10.3390/ijms20143458
Institution: Federal University of São João del-Rei
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: antihypertensive drugs, endothelial function, vascular inflammation, hypertension, endothelial dysfunction, arterial stiffness, third-generation beta-blockers, nebivolol, carvedilol, calcium channel blockers, angiotensin receptor blockers, ACE inhibitors, C-reactive protein, antioxidant activity
Open Access status: gold
Estimated APC paid: $1,824
Award: G29316538
OpenAlex ID: W2962098235
